Atlas Trials

Frontier Biotechnologies Inc.

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Frontier Biotechnologies Inc.

RecordFirmDate
An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers (NCT06510413)Frontier Biotechnologies Inc.2024-07-01
Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 (NCT05675072)Frontier Biotechnologies Inc.2023-01-04
A Study of FB2001 for Inhalation in Healthy Chinese Adults (NCT05583812)Frontier Biotechnologies Inc.2022-10-21
Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study) (NCT05445934)Frontier Biotechnologies Inc.2022-09-14
Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection (NCT05206019)Frontier Biotechnologies Inc.2022-02-16
A Bridging Study of FB2001 in Healthy Subjects (NCT05197179)Frontier Biotechnologies Inc.2021-12-29
Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection (NCT04560569)Frontier Biotechnologies Inc.2021-11-30
Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection (NCT04819347)Frontier Biotechnologies Inc.2021-05-01
The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection (NCT04766931)Frontier Biotechnologies Inc.2021-03-17
Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects (NCT03997734)Frontier Biotechnologies Inc.2019-06-24
Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (NCT03719664)Frontier Biotechnologies Inc.2018-12-17

Track Frontier Biotechnologies Inc. automatically

Every clearance here is in the API, with alerts when new ones post.